Hughes-Wilson Alexandra, Chief Patient Access and Commercial Planning at Mereo Biopharma Group Plc, holds 50.48K shares in Mereo Biopharma Group Plc (Ticker: MREO).
What is the percentage of profitable transactions made by Hughes-Wilson Alexandra?
The percentage of profitable transactions made by Hughes-Wilson Alexandra is ―.
What is the average return per transaction made by Hughes-Wilson Alexandra?
The average return per transaction made by Hughes-Wilson Alexandra is ―.
What stocks does Hughes-Wilson Alexandra hold?
Hughes-Wilson Alexandra holds: MREO stocks.
What was Hughes-Wilson Alexandra’s latest transaction?
Hughes-Wilson Alexandra latest transaction was an Uninformative Sell of $103.53K.
What was Hughes-Wilson Alexandra's most profitable transaction?
Hughes-Wilson Alexandra’s most profitable transaction was an Informative Sell of MREO stock on September 16, 2024. The return on the trade was 5.30%.
What is Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc?
Hughes-Wilson Alexandra's role in Mereo Biopharma Group Plc is Chief Patient Access and Commercial Planning.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.